Abiopharma

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Coherent Launches AxioView™ Imaging Fiber Assemblies for OCT and Multimodal Medical Catheters

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

SC 13G/A (Amended Statement of Ownership) SEC Filing

Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares

Sonida Senior Living Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Sonida Senior Living, Inc. - SNDA

Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Shark Power Detect Vacuums In 2026

The Latest on the Galaxy Z Fold 4

Latest About Samsung Galaxy Buds 2

The Best 75 Inch TV Models for 2026

New Form F-6 - CSL LTD Filed: 2026-01-16 AccNo: 0000950127-26-000007 Size: 426 KB